Total
0
Shares
MedAdvisor extends app to 600 pharmacies via Sigma deal
  • Digital medication company MedAdvisor, has signed a two-year agreement with Sigma Healthcare, a pharmacy retail group
  • Sigma will support the use of MedAdvisor's mobile app by its pharmacy network of over 600 members
  • The virtual app connects with your local pharmacy to help you take medication safely, effectively and on-time
  • The company now has long term contracts with three of the four major pharmacy groups being Sigma, TerryWhite and Chemist Warehouse
  • MedAdvisor shares have gone up 18.4 per cent, with shares trading for 5.8 cents each

MedAdvisor, has signed a two-year agreement with Sigma Healthcare, a pharmacy retail group.

Sigma has a network of over 600 retail pharmacy franchise partners including Amcal, DDS, Guardian, PharmaSave, WholeLife and Chemist King pharmacy brands.

MedAdvisor already has over 400 Sigma group pharmacies already subscribed, however, this agreement will potentially add 200 more.

"Sigma has been a long-term shareholder and supporter of the business and we are pleased to formally document this agreement to help them better support their pharmacies, particularly as the market shifts with ePrescribing," MedAdvisor CEO Robert Read said.

Additionally, the company will provide custom branded versions of its mobile app for promotion and use by a number of Sigma brands.

The MedAdvisor app is a revolutionary software that puts a virtual pharmacist, "Pharmacist Phil" on your device. It connects with your local pharmacy to help you take medication safely, effectively and on-time.

MedAdvisor is available in almost 60 per cent of all Australia pharmacies which represents 12 million patients and over 70 per cent of prescription volume in Australia.

"We are pleased to be able to partner with MedAdvisor to further support electronic prescription readiness as we transition to an ePrescribing environment," Sigma Executive General Manager Jeffs Sells said.

"MedAdvisor continues to innovate and lead the market in both the patient app experience and pharmacy medication management software," Jeff added.

Under this agreement, the total revenue contribution from the Sigma network of brands will increase and is expected to exceed $1 million per year.

The company now has long term contracts with three of the four major pharmacy groups being Sigma, TerryWhite and Chemist Warehouse.

MedAdvisor shares have gone up 18.4 per cent, with shares trading for 5.8 cents each at market close.


Subscribe


MDR by the numbers
More From The Market Herald
Telix Pharmaceuticals (ASX:TLX)- CEO, Dr. Christian Behrenbruch - The Market Herald

" Telix Pharmaceuticals (ASX:TLX) submits NDA for prostate cancer imaging product

Telix Pharmaceuticals (TLX) has submitted a new drug application (NDA) with the U.S.
Recce Pharmaceuticals (ASX:RCE) completes $27.95M capital raise

" Recce Pharmaceuticals (ASX:RCE) completes $27.95M capital raise

Recce Pharmaceuticals (RCE) has completed its capital raise and successfully raised $27.95 million.
Cynata Therapeutics (ASX:CYP) - Managing Director & CEO, Dr Ross Macdonald - The Market Herald

" Cynata Therapeutics (ASX:CYP) receives positive results for stem cell treatment in heart attack

Cynata Therapeutics (CYP) has received positive results for its Cymerus stem cell treatment in a preclinical heart attack model.
PharmaAust Limited (ASX:PAA) - Executive Chairman, Dr Roger Aston - The Market Herald

" PharmAust (ASX:PAA) advances testing against COVID-19

PharmAust (PAA) has advanced its monepantel drugs testing against COVID-19, in the race to find a vaccine for the virus.